Polymorphic forms of naltrexone

Details for Australian Patent Application No. 2004245057 (hide)

International Classifications

Event Publications

8 December 2005 PCT application entered the National Phase

PCT publication WO2004/108084 Priority application(s): WO2004/108084

12 October 2006 Assignment before Grant

Alkermes Controlled Therapeutics, II The application has been assigned to Alkermes, Inc.

31 July 2008 Application Accepted

Published as AU-B-2004245057

18 September 2008 Application for Amendment

The nature of the amendment is: Amend the co-inventor name from Brittain, Harry A. to Brittain, Harry G. . Address for service in Australia - Davies Collison Cave Level 15 1 Nicholson Street Melbourne VIC 3000

15 January 2009 Amendment Made

The nature of the amendment is: Amend the name of the inventor to read FROM: Brittain, Harry A. TO: Brittain, Harry G.

22 January 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.